Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02359799 · ClinicalTrials.gov registry record · NA

Robotic Rehabilitation of Cerebral Palsy

A NA study, sponsored by University of Maryland, Baltimore.

Completed
Registry status
NA
Development phase
5
Enrollment target

NCT02359799: Completed NA study, sponsored by University of Maryland, Baltimore.

NCT02359799 is a NA study that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02359799, a NA study, has completed, sponsored by University of Maryland, Baltimore.

COMPLETED
Registry status
NA
Development phase
5 participants
Enrollment target

Study Summary

The purpose of the study is to examine the outcomes of home-based robot-guided therapy and compare it to laboratory-based robot-guided therapy for impaired ankles in cerebral palsy. Children with spastic cerebral palsy (CP) are randomly placed into two groups, participating in robot-guided stretching and active movement training either in a research lab setting (Lab group) or in a home setting (Home group).

Primary Outcome

The subjects will be asked to use their muscles to move the ankle joint and record the range of motion by the robot.

Interventions

  • DEVICE IntelliStretch

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2019-06-21
Est. Completion 2023-02-28
Phase NA
University of Maryland, Baltimore

560 total trials

What the finished NCT02359799 record still lists

NCT02359799 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 1 intervention - of which IntelliStretch is the first listed.

NCT02359799 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02359799 about?

NCT02359799 is a clinical study titled "Robotic Rehabilitation of Cerebral Palsy". The purpose of the study is to examine the outcomes of home-based robot-guided therapy and compare it to laboratory-based robot-guided therapy for impaired ankles in cerebral palsy. Children with spastic cerebral palsy (CP) are randomly placed into two groups, participating in robot-guided stretchin...

What is the current status of trial NCT02359799?

This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2019-06-21. Estimated completion is 2023-02-28.

What interventions are being tested in trial NCT02359799?

The interventions under investigation include: IntelliStretch (DEVICE).

Who is sponsoring clinical trial NCT02359799?

This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02359799's enrollment target sits among peer trials

5 1988th of 2000 higher than 5 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02359799, the US trial registry maintained by the National Library of Medicine. NCT02359799 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.